Dobutamine Hydrochloride Injection

1 It has a positive inotropic effect on the myocardium, mainly acting on β1 receptors, and has relatively little effect on β2 and α receptors. 2 It can directly excite the cardiac β1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output. 3 It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output. 4 It can reduce ventricular filling pressure and promote atrioventricular node conduction. 5 Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase. 6 Due to increased cardiac output, renal blood flow and urine volume often increase. 7nbs

The main ingredient and chemical name of this product are: 4-[2-[[1-methyl-3-(4-hydroxyphenyl)propyl]amino]ethyl]-1,2-benzenediol hydrochloride

This product is a colorless clear liquid

It is used as a short-term supportive treatment for heart failure caused by decreased myocardial contractility in patients with organic heart disease, including low output syndrome caused by open heart surgery.

The commonly used dose for adults is dobutamine diluted in 5% glucose solution or 0.9% sodium chloride injection, and then given at a drip rate of 2.5-10ug/kg per minute. At doses below 15ug/kg per minute, heart rate and peripheral vascular resistance remain basically unchanged; occasionally >15ug/kg per minute is used, but it should be noted that excessive doses may still accelerate the heart rate and produce arrhythmias.

There may be palpitations, nausea, headache, chest pain, shortness of breath, etc. If systolic blood pressure increases (mostly by 1.33-2.67Kpa (10-20mmHg), a few by 6.67Kpa (50mmHg) or more), heart rate increases (mostly by 5-10 beats per minute, a few by more than 30 beats per minute), it is related to the dosage and the dosage should be reduced or the medication should be suspended.

This experiment has not been conducted and there are no reliable references.

Precautions for children: There is a lack of research on the use of this product in children. Precautions for pregnancy and lactation: No such test has been conducted and there are no reliable references. Precautions for the elderly: No research has been conducted in the elderly, but the application is not expected to be restricted.

1. When used with general anesthetics, especially cyclopropane and halothane, the possibility of ventricular arrhythmias increases. 2. When used with beta-blockers, it can antagonize the effect of this product on beta-1 receptors, resulting in the dominance of alpha receptors and an increase in the total resistance of peripheral blood vessels. 3. When used with sodium nitroprusside, it can lead to a slight increase in cardiac output and a slight decrease in pulmonary wedge pressure. 4. This product must not be mixed with alkaline drugs such as sodium bicarbonate.

Shade from light, store in a sealed container

2ml:20mg

36 months

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

• Founded in:

  2001-06-22

• Address:

  No. 118, Huagong Road, Dongtou District, Wenzhou

• Tax NO.:

  913303007303249630

• Registered Funds:

  327.30432 million yuan

• Website:

  Log in to view

• Email:

  Log in to view